Replies to post #81565 on Amarin Corp Plc (AMRN)

[sts66]

I never wanted to spell the crime out for them

I see - that's why I can't recall you ever specifically stating what the violation was, I assume?

I think you got them by the ballz, BB - it's clear this line from the agenda is in no way, shape, or form what the real AC agenda turned into:

This supplemental application proposesconcomitant use with an inhibitor of HMG-CoA reductase (statin) to reduce triglycerides, non-high density lipoprotein cholesterol, apolipoprotein B, low-density lipoprotein cholesterol, total cholesterol, and very low density lipoprotein cholesterol in adults with mixed dyslipidemia and coronary heart disease (CHD) or a CHD risk equivalent.

Go get'em!

Side note: I also assume during your meeting with AMRN they agreed you (and they) had a good legal case, but they didn't want to antagonize FDA a 3rd time and risk R-IT retaliation?